NOV 11, 2015 10:16 AM PST

Scientists Are One Step Closer to Improving the Flu Vaccine

WRITTEN BY: Kara Marker
A single signaling protein required for a successful immune attack against viral infections may be the key to improving the influenza vaccine. 

Tumor progression locus 2 (Tpl2) protein regulates inflammation during the immune response to viral invaders by managing the production of interferon proteins. Scientists from the University of Georgia (UGA) wanted to find out exactly how Tpl2 regulates the immune response through this interaction, and they published their findings in a recent PLoS Pathogens article.

Interferons are secreted by host immune cells when the body is invaded by pathogens (Nature). Interferons then recruit more immune cells to take care of the infection. 

In order to determine the specific action of Tpl2 during viral infection, the team from UGA compared the response of Tpl2 knockout mice with functional mice to an influenza infection. The Tpl2 knockout mice ended up having ten times as much virus in their lungs than the functional mice. In addition, they had a reduced cytotoxic T cell count, lymphocytes that are needed to clear flu virus out of the lungs. 

When the scientists looked further into the interferon content of the two groups of mice, they found that while the Tpl2 knockout mice produced a normal amount of Type I interferon proteins, they produced significantly less Type III interferons than the functional mice. This distinction is important since Type III interferons are more "highly expressed at mucosal sites," indicating their necessity for a successful immune attack against the flu. 

"Ultimately the goal is to generate better vaccines so that we can drive immunologic memory and protect people against subsequent infections," Dr. Wendy Watford said of the study's significance. 

Although immediately useful for the flu virus, this discovery could also be beneficial for vaccine research for other viruses infecting mucosal sites like rotavirus and syncytial virus. The group from UGA plans to continue looking at the role of Tpl2 in different disease settings. 

Watch the following animation to see how interferons work in the immune response to viruses.
Source: University of Georgia
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: havin ...
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Are COVID-19 Antibody Tests a Back-to-Work Pass?
Although treatments and vaccines against COVID-19 may still be months away, antibody tests are becoming more widespread. ...
APR 22, 2020
Immunology
APR 22, 2020
Scientists Engineer Custom Antiviral Receptors to Fight COVID-19
The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are e ...
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
MAY 06, 2020
Drug Discovery & Development
MAY 06, 2020
Breakthrough in Antibody Treatment for COVID-19
Israeli scientists have announced significant progress in isolating an antibody that may be effective in treating those ...
MAY 15, 2020
Immunology
MAY 15, 2020
Support the Microbiome So the Immune System Can Do Its Job
Research has long connected the human microbiome and immune system function, and now a recent study pinpoints a key poin ...
Loading Comments...